Self-report measures of medication adherence behavior: recommendations on optimal use

Translational Behavioral Medicine

Volumn 5, Issue 4, 2015, Pages 470-482

  Stirratt, Michael J ^a   Dunbar Jacob, Jacqueline ^b   Crane, Heidi M ^c   Simoni, Jane M ^c   Czajkowski, Susan ^d   Hilliard, Marisa E ^e   Aikens, James E ^f   Hunter, Christine M ^g   Velligan, Dawn I ^h   Huntley, Kristen ⁱ   Ogedegbe, Gbenga ^j   Rand, Cynthia S ^k   Schron, Eleanor ^l   Nilsen, Wendy J ^m  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^j NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l NATIONAL EYE INSTITUTE   (United States)

^m NATIONAL SCIENCE FOUNDATION   (United States)

more..

Author keywords

Adherence; Compliance; Medication; Self management; Self report

Indexed keywords

CHRONIC DISEASE; CONVERGENT VALIDITY; CRITERION RELATED VALIDITY; HEALTH CARE SYSTEM; HUMAN; MEDICAL RESEARCH; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECALL; REVIEW; SELF REPORT; SENSITIVITY AND SPECIFICITY; SOCIAL DESIRABILITY;

EID: 84936814439     PISSN: 18696716     EISSN: 16139860     Source Type: Journal    
DOI: 10.1007/s13142-015-0315-2     Document Type: Review

References (135)

1. Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Medical Research Methodology. 2011; 11: 149.
2. Gonzalez JS, Schneider HE. Methodological issues in the assessment of diabetes treatment adherence. Current Diabetes Reports. 2011; 11: 472-479.
3. Hall KS, White KO, Reame N, Westhoff C. Studying the use of oral contraception: a review of measurement approaches. Journal of Women's Health. 2010; 19: 2203-2210.
4. Paschal AM, Hawley SR, St Romain T, Ablah E. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia. 2008; 49: 1115-1122.
5. Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior. 2006; 10: 227-245.
6. Velligan DI, Lam YW, Glahn DC, et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophrenia Bulletin. 2006; 32: 724-742.
7. Nguyen TM, Caze AL, Cottrell N. (2013) What are validated self-report adherence scales really measuring?: a systematic review. British Journal of Clinical Pharmacology
8. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Medical Care. 2004; 42: 649-652.
9. Wilson IB, Carter AE, Berg KM. Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Current HIV/AIDS Reports. 2009; 6: 177-186.
10. Osterberg L, Blaschke T. Adherence to medication. The New England Journal of Medicine. 2005; 353: 487-497.
11. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology. 2012; 73: 691-705.
12. Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS Jr. Improving the measurement of self-reported medication nonadherence. Journal of Clinical Epidemiology. 2011; 64: 250-254.
13. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. International Journal of Clinical Practice. 2008; 62: 76-87.
14. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Medical Care. 2002; 40: 794-811.
15. Granger BB, Swedberg K, Ekman I, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005; 366: 2005-2011.
16. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007; 297: 177-186.
17. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333: 15.
18. Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics. 2011; 33: 74-109.
19. Hood KK, Peterson CM, Rohan JM, Drotar D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009; 124: e1171-e1179.
20. Riegel B, Knafl GJ. Electronically monitored medication adherence predicts hospitalization in heart failure patients. Patient Prefer Adherence. 2013; 8: 1-13.
21. Dragomir A, Cote R, Roy L, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Medical Care. 2010; 48: 418-425.
22. Pladevall M, Williams LK, Potts LA, et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004; 27: 2800-2805.
23. Marin D, Bazeos A, Mahon FX, et al. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. Journal of Clinical Oncology. 2010; 28: 2381-2388.
24. Dragomir A, Cote R, White M, et al. Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value in Health. 2010; 13: 87-94.
25. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008; 28: 437-443.
26. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004; 27: 1218-1224.
27. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care. 2004; 42: 200-209.
28. Vink NM, Klungel OH, Stolk RP, Denig P. Comparison of various measures for assessing medication refill adherence using prescription data. Pharmacoepidemiology and Drug Safety. 2009; 18: 159-165.
29. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. Journal of Managed Care Pharmacy. 2009; 15: 728-740.
30. de Klerk E, van der Heijde D, Landewe R, et al. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. Journal of Rheumatology. 2003; 30: 44-54.
31. Mannheimer S, Thackeray L, Huppler Hullsiek K, et al. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care. 2008; 20: 161-169.
32. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. Journal of Acquired Immune Deficiency Syndromes. 2006; 43(Suppl 1): S79-S87.
33. Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. Journal of Acquired Immune Deficiency Syndromes. 2006; 43(Suppl 1): S149-S155.
34. Quittner AL, Modi AC, Lemanek KL, Ievers-Landis CE, Rapoff MA. Evidence-based assessment of adherence to medical treatments in pediatric psychology. Journal of Pediatric Psychology. 2008; 33: 916-936. discussion 937–918.
35. Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuring medication adherence in research. AIDS and Behavior. 2013; 17: 284-297.
36. Kimmerling M, Wagner G, Ghosh-Dastidar B. Factors associated with accurate self-reported adherence to HIV antiretrovirals. International Journal of STD and AIDS. 2003; 14: 281-284.
37. Knobel H, Alonso J, Casado JL, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS. 2002; 16: 605-613.
38. Wagner G. Utility of self-reported antiretroviral adherence: Comment on Simoni et al. (2006). AIDS and Behavior. 2006; 10: 247-248.
39. Simoni JM, Montgomery A, Martin E, et al. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007; 119: e1371-e1383.
40. Dobbels F, Berben L, De Geest S, et al. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation. 2010; 90: 205-219.
41. Bangsberg DR. Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: the past, the present, and the future. AIDS and Behavior. 2006; 10: 249-251.
42. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension. 2008; 10: 348-354.
43. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000; 12: 255-266.
44. Berg KM, Wilson IB, Li X, Arnsten JH. Comparison of antiretroviral adherence questions. AIDS and Behavior. 2012; 16: 461-468.
45. Greenlaw SM, Yentzer BA, O'Neill JL, Balkrishnan R, Feldman SR. Assessing adherence to dermatology treatments: a review of self-report and electronic measures. Skin Research and Technology. 2010; 16: 253-258.
46. Rand CS. "I Took the Medicine Like You Told Me, Doctor": Self-Report of Adherence with Medical Regimens. In: Stone AA, Turkkan JS, Bachrach CA, et al., eds. The science of self-report: Implications for research and practice. Mahwah, NJ: Lawrence Erlbaum Associates; 2000: 257-276.
47. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. Journal of Acquired Immune Deficiency Syndromes. 2005; 38: 445-448.
48. Kahana SY, Rohan J, Allison S, Frazier TW, Drotar D. A meta-analysis of adherence to antiretroviral therapy and virologic responses in HIV-infected children, adolescents, and young adults. AIDS and Behavior. 2013; 17: 41-60.
49. Usitalo A, Leister E, Tassiopoulos K, et al. Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection. AIDS Care. 2014; 26: 107-115.
50. Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. Journal of Clinical Epidemiology. 2010; 63: 299-306.
51. Dunbar-Jacob J, Sereika SM, Houze M, Luyster FS, Callan JA. Accuracy of measures of medication adherence in a cholesterol-lowering regimen. Western Journal of Nursing Research. 2012; 34: 578-597.
52. Voils CI, Maciejewski ML, Hoyle RH, et al. Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Medical Care. 2012; 50: 1013-1019.
53. Gonzalez JS, Schneider HE, Wexler DJ, et al. Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care. 2013; 36: 831-837.
54. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Diseases. 2001; 33: 1417-1423.
55. Shi L, Liu J, Koleva Y, et al. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. PharmacoEconomics. 2010; 28: 1097-1107.
56. Shi L, Liu J, Fonseca V, et al. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health and Quality of Life Outcomes. 2010; 8: 99.
57. Bova CA, Fennie KP, Knafl GJ, et al. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS and Behavior. 2005; 9: 103-110.
58. Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behavior. 2006.
59. Sajatovic M, Velligan DI, Weiden PJ, Valenstein MA, Ogedegbe G. Measurement of psychiatric treatment adherence. Journal of Psychosomatic Research. 2010; 69: 591-599.
60. Steiner JF. Self-reported adherence measures: what do they assess and how should we use them? Medical Care. 2012; 50: 1011-1012.
61. Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS Jr. Response to Morisky & DiMatteo: Improving the measurement of self-reported medication nonadherence. Journal of Clinical Epidemiology. 2011; 64: 250-254.
62. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Progress in Cardiovascular Nursing. 2000; 15: 90-96.
63. Krousel-Wood M, Islam T, Webber LS, et al. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. The American Journal of Managed Care. 2009; 15: 59-66.
64. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986; 24: 67-74.
65. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of nonadherence to hypertension treatment in an inner-city minority population. American Journal of Public Health. 1992; 82: 1607-1612.
66. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Education and Counseling. 1999; 37: 113-124.
67. Steiner JF. Rethinking adherence. Annals of Internal Medicine. 2012; 157: 580-585.
68. Feldman BJ, Fredericksen RJ, Crane PK, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS and Behavior. 2013; 17: 307-318.
69. Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS and Behavior. 2008; 12: 86-94.
70. Wilson IB, Fowler FJ, Jr., Cosenza CA, et al. (2013) Cognitive and Field Testing of a New Set of Medication Adherence Self-Report Items for HIV Care. AIDS Behavior.
71. Nieuwkerk PT, de Boer-van der Kolk IM, Prins JM, Locadia M, Sprangers MA. Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding. Antivir Ther. 2010; 15: 913-916.
72. Velligan DI, Weiden PJ, Sajatovic M, et al. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines. Journal of Psychiatric Practice. 2010; 16: 34-45.
73. Tourangeau R, Smith TW. Asking sensitive questions: the impact of data collection mode, question format, and question context. Public Opinion Quarterly. 1996; 2: 275-304.
74. Islam MM, Topp L, Conigrave KM, et al. The reliability of sensitive information provided by injecting drug users in a clinical setting: clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care. 2012; 24: 1496-1503.
75. Newman JC, Des Jarlais DC, Turner CF, et al. The differential effects of face-to-face and computer interview modes. American Journal of Public Health. 2002; 92: 294-297.
76. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999; 353: 1657-1661.
77. Kissinger P, Rice J, Farley T, et al. Application of computer-assisted interviews to sexual behavior research. American Journal of Epidemiology. 1999; 149: 950-954.
78. Locke SE, Kowaloff HB, Hoff RG, et al. Computer-based interview for screening blood donors for risk of HIV transmission. JAMA. 1992; 268: 1301-1305.
79. Sanders GD, Owens DK, Padian N, et al. A computer-based interview to identify HIV risk behaviors and to assess patient preferences for HIV-related health states. Proceedings of the Annual Symposium on Computer Applications in Medical Care. 1994:20–24.
80. Wilson AS, Kitas GD, Carruthers DM, et al. Computerized information-gathering in specialist rheumatology clinics: an initial evaluation of an electronic version of the Short Form 36. Rheumatology (Oxford). 2002; 41: 268-273.
81. Velikova G, Wright EP, Smith AB, et al. Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. Journal of Clinical Oncology. 1999; 17: 998-1007.
82. Aiello EJ, Taplin S, Reid R, et al. In a randomized controlled trial, patients preferred electronic data collection of breast cancer risk-factor information in a mammography setting. Journal of Clinical Epidemiology. 2006; 59: 77-81.
83. Chinman M, Young AS, Schell T, Hassell J, Mintz J. Computer-assisted self-assessment in persons with severe mental illness. Journal of Clinical Psychiatry. 2004; 65: 1343-1351.
84. Perlis TE, Des Jarlais DC, Friedman SR, Arasteh K, Turner CF. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction. 2004; 99: 885-896.
85. Kurth AE, Martin DP, Golden MR, et al. A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sexually Transmitted Diseases. 2004; 31: 719-726.
86. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. American Journal of Epidemiology. 2000; 152: 99-106.
87. Ghanem KG, Hutton HE, Zenilman JM, Zimba R, Erbelding EJ. Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sexually Transmitted Infections. 2005; 81: 421-425.
88. Hanscom B, Lurie JD, Homa K, Weinstein JN. Computerized questionnaires and the quality of survey data. Spine. 2002; 27: 1797-1801.
89. Bock B, Niaura R, Fontes A, Bock F. Acceptability of computer assessments among ethnically diverse, low-income smokers. American Journal of Health Promotion. 1999; 13: 299-304.
90. Castle T, Cunningham MA, Marsh GM. Antidepressant medication adherence via interactive voice response telephone calls. The American Journal of Managed Care. 2012; 18: e346-e355.
91. Vollmer WM, Feldstein A, Smith DH, et al. Use of health information technology to improve medication adherence. The American Journal of Managed Care. 2011; 17: SP79-SP87.
92. Hettema JE, Hosseinbor S, Ingersoll KS. Feasibility and reliability of interactive voice response assessment of HIV medication adherence: research and clinical implications. HIV Clin Trials. 2012; 13: 271-277.
93. Harris LT, Lehavot K, Huh D, et al. Two-way text messaging for health behavior change among human immunodeficiency virus-positive individuals. Telemed J E Health. 2010; 16: 1024-1029.
94. Granholm E, Ben-Zeev D, Link PC, Bradshaw KR, Holden JL. Mobile assessment and treatment for schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations. Schizophrenia Bulletin. 2012; 38: 414-425.
95. Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. Journal of Medical Internet Research. 2012; 14: e51.
96. Bender BG, Bartlett SJ, Rand CS, et al. Impact of interview mode on accuracy of child and parent report of adherence with asthma-controller medication. Pediatrics. 2007; 120: e471-e477.
97. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials. 2004; 5: 74-79.
98. Kalichman SC, Amaral CM, Swetzes C, et al. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. Journal of the International Association of Physicians in AIDS Care (Chicago, Ill). 2009; 8: 367-374.
99. Walsh JC, Dalton M, Gazzard BG. Adherence to combination antiretroviral therapy assessed by anonymous patient self-report. AIDS. 1998; 12: 2361-2363.
100. Simoni J, Huh D, Wang Y, et al. The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: findings from the MACH14 study. AIDS Behav. 2014; 18: 2285-2290.
101. Bangsberg DR, Hecht FM, Clague H, et al. Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2001; 26: 435-442.
102. Byerly M, Fisher R, Whatley K, et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Research. 2005; 133: 129-133.
103. Miller LG, Liu H, Hays RD, et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy? Journal of General Internal Medicine. 2002; 17: 1-11.
104. Ose D, Mahler C, Vogel I, et al. Let's talk about medication: concordance in rating medication adherence among multimorbid patients and their general practitioners. Patient Prefer Adherence. 2012; 6: 839-845.
105. Velligan DI, Wang M, Diamond P, et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatric Services. 2007; 58: 1187-1192.
106. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Annals of Internal Medicine. 2012; 156: 817-833.
107. Wolford G, Rosenberg SD, Rosenberg HJ, et al. A clinical trial comparing interviewer and computer-assisted assessment among clients with severe mental illness. Psychiatric Services. 2008; 59: 769-775.
108. Lofland JH, Schaffer M, Goldfarb N. Evaluating health-related quality of life: cost comparison of computerized touch-screen technology and traditional paper systems. Pharmacotherapy. 2000; 20: 1390-1395.
109. Williams CA, Templin T, Mosley-Williams AD. Usability of a computer-assisted interview system for the unaided self-entry of patient data in an urban rheumatology clinic. Journal of the American Medical Informatics Association. 2004; 11: 249-259.
110. Smith MW, Sharit J, Czaja SJ. Aging, motor control, and the performance of computer mouse tasks. Human Factors. 1999; 41: 389-396.
111. Kim J, Trace D, Meyers K, Evens M. An empirical study of the Health Status Questionnaire System for use in patient-computer interaction. Proceedings AMIA Annual Fall Symptom. 1997:86–90.
112. Feldman BJ, Fredericksen RJ, Crane PK, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behavior. 2012.
113. Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Annals of Pharmacotherapy. 2001; 35: 997-1003.
114. Duncan NA, Kronenberger WG, Roberson CP, Shapiro AD. VERITAS-PRN: a new measure of adherence to episodic treatment regimens in haemophilia. Haemophilia. 2010; 16: 47-53.
115. Reynolds NR, Sun J, Nagaraja HN, et al. Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis. Journal of Acquired Immune Deficiency Syndromes. 2007; 46: 402-409.
116. Munoz-Moreno JA, Fumaz CR, Ferrer MJ, et al. Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study. AIDS Research and Human Retroviruses. 2007; 23: 1166-1175.
117. Godin G, Gagne C, Naccache H. Validation of a self-reported questionnaire assessing adherence to antiretroviral medication. AIDS Patient Care and STDs. 2003; 17: 325-332.
118. Amico KR, Fisher WA, Cornman DH, et al. Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. Journal of Acquired Immune Deficiency Syndromes. 2006; 42: 455-459.
119. Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. Journal of Clinical Epidemiology. 2006; 59: 650-651.
120. Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. Journal of Clinical Epidemiology. 2008; 61: 282-288.
121. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clinical Transplantation. 1994; 8: 550-557.
122. Tucker CM, Petersen S, Herman KC, et al. Self-regulation predictors of medication adherence among ethnically different pediatric patients with renal transplants. Journal of Pediatric Psychology. 2001; 26: 455-464.
123. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Education and Counseling. 2005; 59: 13-20.
124. Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney International. 2009; 75: 1223-1229.
125. Byerly MJ, Nakonezny PA, Rush AJ. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research. 2008; 100: 60-69.
126. Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. The American Journal of Psychiatry. 2002; 159: 1927-1929.
127. Wicks P, Massagli M, Kulkarni A, Dastani H. Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ). Journal of Medical Internet Research. 2011; 13, e12.
128. Breuil V, Cortet B, Cotte FE, et al. Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporosis International. 2012; 23: 445-455.
129. de Klerk E, van der Heijde D, van der Tempel H, van der Linden S. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. Journal of Rheumatology. 1999; 26: 2635-2641.
130. McHorney CA, Victor Spain C, Alexander CM, Simmons J. Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims. Clinical Therapeutics. 2009; 31: 2584-2607.
131. Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value in Health. 2009; 12: 118-123.
132. DiMatteo MR, Sherbourne CD, Hays RD, et al. Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychology. 1993; 12: 93-102.
133. Wu JR, Chung M, Lennie TA, Hall LA, Moser DK. Testing the psychometric properties of the Medication Adherence Scale in patients with heart failure. Heart and Lung. 2008; 37: 334-343.
134. Orwig D, Brandt N, Gruber-Baldini AL. Medication management assessment for older adults in the community. Gerontologist. 2006; 46: 661-668.
135. Zelikovsky N, Schast AP. Eliciting accurate reports of adherence in a clinical interview: development of the Medical Adherence Measure. Pediatric Nursing. 2008; 34: 141-146.